Contract Research
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
196
NCT06784778
Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.
Phase: N/A
Role: Lead Sponsor
Start: Jul 12, 2024
Completion: Jul 31, 2027
Loading map...